NARA Discovery
Article Details
← Back to Search Results
Journal Article

Human papillomavirus infection, cervical cancer and the less explored role of trace elements

Anne Boyina Sravani; Vivek Ghate; Shaila Lewis
Biological Trace Element Research · Vol. 201, Issue 3 · pp. 1026-1050 · 2023

Abstract

Cervical cancer is an aggressive type of cancer affecting women worldwide. Many affected individuals rely on smear tests for the diagnosis, surgery, chemotherapy, or radiation for their treatment. However, due to a broad set of undesired results and side-effects associated with the existing protocols, the search for better diagnostic and therapeutic interventions is a never-ending pursuit. In the purview, the bio-concentration of trace elements (copper, selenium, zinc, iron, arsenic, manganese, and cadmium) is seen to fluctuate during the occurrence of cervical cancer and its progression from pre-cancerous to metastatic nature. Thus, during the occurrence of cervical cancer, the detection of trace elements and their supplementation will prove to be highly advantageous in developing diagnostic tools and therapeutics, respectively. This review provides a detailed overview of cervical cancer, its encouragement by human papillomavirus infections, the mechanism of pathology, and resistance. Majorly, the review emphasizes the less explored role of trace elements, their contribution to the growth and inhibition of cervical cancer. Numerous clinical trials have been listed, thereby providing a comprehensive reference to the exploration of trace elements in the management of cervical cancer.

Bibliographic Information

JournalBiological Trace Element Research
PublisherSpringer
Publication Date2023-03-01
Publication Year2023
Volume201
Issue3
Pages1026-1050
Document TypeJournal Article
eISSN1559-0720
DOI10.1007/s12011-022-03226-2

Access Information

NARA Access Coverage1979-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12011
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.